In a report released on November 15, Giorgio Tavolini from Intermonte maintained a Buy rating on Fine Foods & Pharmaceuticals N.T.M. SpA (FF – Research Report), with a price target of €12.00.
Giorgio Tavolini’s rating is based on several factors, including Fine Foods & Pharmaceuticals N.T.M. SpA’s strong performance in maintaining robust margins and delivering a positive EBITDA surprise. The company’s revised pricing strategy has effectively mitigated costs related to raw materials and packaging, supporting overall financial performance. Additionally, the company successfully managed its net debt and capital expenditure, which positions it well for future growth.
Fine Foods & Pharmaceuticals has demonstrated resilience in its business divisions, with notable performance in the Pharma BU and expectations for recovery in other segments. The management’s confidence and strategic deferral of capital expenditures to 2025 are seen as positive indicators for the company’s financial health. As a leading Italian CDMO, Fine Foods is well-positioned to capture market share and pursue M&A opportunities, further justifying the Buy rating and the target price set by Tavolini.
FF’s price has also changed slightly for the past six months – from EUR8.500 to EUR8.160, which is a -4.00% drop .
TipRanks tracks over 100,000 company insiders, identifying the select few who excel in timing their transactions. By upgrading to TipRanks Premium, you will gain access to this exclusive data and discover crucial insights to guide your investment decisions. Begin your TipRanks Premium journey today.
Fine Foods & Pharmaceuticals N.T.M. SpA (FF) Company Description:
Read More on IT:FF:
